Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GEM: Metformin with Gemcitabine and Erlotinib in Pancreatic Cancer
NCT01210911Phase 2Completed
- Sponsor
- University of Amsterdam
- Start
- Aug 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in pancreatic cancer (PC), sponsored by University of Amsterdam. Started Aug 2010; status: completed.
02
Drugs
metformin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT01210911.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01210911.